Balch C M, Soong S J, Smith T, Ross M I, Urist M M, Karakousis C P, Temple W J, Mihm M C, Barnhill R L, Jewell W R, Wanebo H J, Desmond R
Johns Hopkins Medical Center, Baltimore, Maryland, USA.
Ann Surg Oncol. 2001 Mar;8(2):101-8. doi: 10.1007/s10434-001-0101-x.
The Intergroup Melanoma Surgical Trial began in 1983 to examine the optimal surgical margins of excision for primary melanomas of intermediate thickness (i.e., 1-4 mm). There is now a median 10-year follow-up.
There were two cohorts entered into a prospective multi-institutional trial: (1) 468 patients with melanomas on the trunk or proximal extremity who randomly received a 2 cm or 4 cm radial excision margin and (2) 272 patients with melanomas on the head, neck, or distal extremities who received a 2 cm radial excision margin.
A local recurrence (LR) was associated with a high mortality rate, with a 5-year survival rate of only 9% (as a first relapse) or 11% (anytime) compared with an 86% survival for those patients who did not have a LR (P < .0001). The 10-year survival for all patients with a LR was 5%. The 10-year survival rates were not significantly different when comparing 2 cm vs. 4 cm margins of excision (70% vs. 77%) or comparing the management of the regional lymph nodes (observation vs. elective node dissection). The incidences of LR were the same for patients having a 2 cm vs. 4 cm excision margin regardless of whether the comparisons were made as first relapse (0.4% vs. 0.9%) or at anytime (2.1% vs. 2.6%). When analyzed by anatomic site, the LR rates were 1.1% for melanomas arising on the proximal extremity, 3.1% for the trunk, 5.3% for the distal extremities, and 9.4% for the head and neck. The most profound influence on LR rates was the presence or absence of ulceration; it was 6.6% vs. 1.1% in the randomized group involving the trunk and proximal extremity and was 16.2% vs. 2.1% in the non-randomized group involving the distal extremity and head and neck (P < .001). A multivariate (Cox) regression analysis showed that ulceration was an adverse and independent factor (P = .0001) as was head and neck melanoma site (P = .01), while the remaining factors were not significant (all with P > .12).
For this group of melanoma patients, a local recurrence is associated with a high mortality rate, a 2-cm margin of excision is safe and ulceration of the primary melanoma is the most significant prognostic factor heralding an increased risk for a local recurrence.
1983年开展了黑色素瘤组间外科试验,以研究中等厚度(即1 - 4毫米)原发性黑色素瘤的最佳手术切除切缘。目前有10年的中位随访期。
前瞻性多机构试验纳入了两个队列:(1)468例躯干或近端肢体黑色素瘤患者,随机接受2厘米或4厘米的径向切除切缘;(2)272例头、颈或远端肢体黑色素瘤患者,接受2厘米的径向切除切缘。
局部复发(LR)与高死亡率相关,局部复发患者的5年生存率仅为9%(首次复发时)或11%(任何时间),而未发生局部复发的患者5年生存率为86%(P <.0001)。所有发生局部复发患者的10年生存率为5%。比较2厘米与4厘米切除切缘时,10年生存率无显著差异(分别为70%和77%),比较区域淋巴结的处理方式(观察与选择性淋巴结清扫)时,10年生存率也无显著差异。无论比较首次复发时(0.4%对0.9%)还是任何时间(2.1%对2.6%),2厘米与4厘米切除切缘患者的局部复发发生率相同。按解剖部位分析,近端肢体黑色素瘤的局部复发率为1.1%,躯干为3.1%,远端肢体为5.3%,头颈部为9.4%。对局部复发率影响最显著的是溃疡的有无;在涉及躯干和近端肢体的随机分组中,溃疡患者的局部复发率为6.6%,无溃疡患者为1.1%;在涉及远端肢体和头颈部的非随机分组中,溃疡患者的局部复发率为16.2%,无溃疡患者为2.1%(P <.001)。多因素(Cox)回归分析显示,溃疡是一个不良且独立的因素(P =.0001),头颈部黑色素瘤部位也是(P =.01),而其他因素均无显著意义(P均>.12)。
对于这组黑色素瘤患者,局部复发与高死亡率相关,2厘米的切除切缘是安全的,原发性黑色素瘤的溃疡是预示局部复发风险增加的最重要预后因素。